The Effect of Vitamin D Supplementation on COVID-19 Recovery

NCT04883203 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2021-05-12

No results posted yet for this study

Summary

The COVID-19 caused by SARS-CoV-2 has transmitted quickly as a global public health emergency. The median duration for Sars-CoV-2 carrying in COVID-19 patients was 20 days (IQR 16-28) What is the role of vitamin D supplementation on the recovery time of asymptomatic and pauci-symptomatic COVID-19 subjects? the intervention group will have vitamin D supplementation (200,000 IU / 1 ml of Cholecalciferol (1 ml) Oral form). Control group will have a placebo treatment (physiological saline).

the negative RT-PCR date will be compared in the two groups

Conditions

  • Covid19

Interventions

DRUG

Vit-D 0.2 MG/ML Oral Solution [Calcidol]

ARM 1 : Cholecalciferol 200,000 IU / 1 mL .

DRUG

Physiological Irrigating Solution

ARM 2 : placebo

Sponsors & Collaborators

  • Loussaief Chawki

    collaborator UNKNOWN
  • Nissaf Ben Alaya

    collaborator UNKNOWN
  • Cyrine Ben Nasrallah

    collaborator UNKNOWN
  • Manel Ben Belgacem

    collaborator UNKNOWN
  • Hela Abroug

    collaborator UNKNOWN
  • Imen Zemni

    collaborator UNKNOWN
  • Manel Ben fredj

    collaborator UNKNOWN
  • Wafa Dhouib

    collaborator UNKNOWN
  • University of Monastir

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-22
Primary Completion
2020-09-30
Completion
2020-10-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883203 on ClinicalTrials.gov